Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA

Santen is proud to announce and welcome Dr Sophia Pathai (MBBS, PhD, MSc MRCOphth, MFPM) as the new Vice President (VP) of Medical Affairs EMEA.

Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA

Dr Pathai’s passion for improving eye care around the world has inspired her career over the past 20 years. As a qualified ophthalmologist and clinical scientist, she practiced medical and surgical ophthalmology in varied clinical environments worldwide. She also spent a year on the ORBIS Flying Eye Hospital as a staff ophthalmologist and continues to work with non-profit organisations such as Médecins Sans Frontières to improve eye care in settings such as Myanmar, India and sub-Saharan Africa.

In her new role, Sophia is responsible for leading the strategic development of Medical Affairs EMEA. For FY20, this will involve leading medical engagement by leveraging digital media. Sophia will also focus on driving excellence in key business processes, such as integrated evidence planning. Dr Pathai will report directly to Luis Iglesias, Head of EMEA and Corporate Officer.

Dr Pathai also brings a wealth of experience from the pharmaceutical and medical devices sector. Most recently, Dr Pathai served as the Medical Affairs Director at Johnson & Johnson Surgical Vision (Asia Pacific & Japan), where she led the medical affairs strategy for the launch of three surgical ophthalmic devices.

I have been privileged to serve ophthalmology patients as an ophthalmologist, clinical scientist and most recently, within Medical Affairs in the pharmaceuticals and devices sector. I know that at Santen, every strategy where we can contribute starts and ends with our patients, and that’s why I am delighted to join this organisation where ophthalmology is our singular focus. With the breadth of our experience and expertise as an ophthalmology-focused organisation, I’m very excited about what the future holds for patients, ophthalmologists and for all of us.”

Dr Sophia Pathai, Vice President, Santen Medical Affairs EMEA

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Santen Pharmaceutical Co., Ltd.. (2020, May 21). Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20200521/Santen-appoints-Dr-Sophia-Pathai-as-new-Vice-President-of-Medical-Affairs-EMEA.aspx.

  • MLA

    Santen Pharmaceutical Co., Ltd.. "Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20200521/Santen-appoints-Dr-Sophia-Pathai-as-new-Vice-President-of-Medical-Affairs-EMEA.aspx>.

  • Chicago

    Santen Pharmaceutical Co., Ltd.. "Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA". News-Medical. https://www.news-medical.net/news/20200521/Santen-appoints-Dr-Sophia-Pathai-as-new-Vice-President-of-Medical-Affairs-EMEA.aspx. (accessed November 21, 2024).

  • Harvard

    Santen Pharmaceutical Co., Ltd.. 2020. Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20200521/Santen-appoints-Dr-Sophia-Pathai-as-new-Vice-President-of-Medical-Affairs-EMEA.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.